4//SEC Filing
10X Capital Management, LLC 4
Accession 0001493152-18-008739
CIK 0001133416other
Filed
Jun 13, 8:00 PM ET
Accepted
Jun 14, 7:32 PM ET
Size
12.7 KB
Accession
0001493152-18-008739
Insider Transaction Report
Form 4
10X Fund, L.P.
10% Owner
Transactions
- Sale
Common Stock
2018-06-13$6.59/sh−60,000$395,400→ 2,949,786 total(indirect: See footnote) - Sale
Common Stock
2018-06-13$7.09/sh−60,000$425,400→ 2,889,786 total(indirect: See footnote) - Sale
Common Stock
2018-06-13$7.97/sh−28,140$224,276→ 2,801,646 total(indirect: See footnote) - Sale
Common Stock
2018-06-13$7.47/sh−60,000$448,200→ 2,829,786 total(indirect: See footnote)
10X Capital Management, LLC
10% Owner
Transactions
- Sale
Common Stock
2018-06-13$7.47/sh−60,000$448,200→ 2,829,786 total(indirect: See footnote) - Sale
Common Stock
2018-06-13$7.09/sh−60,000$425,400→ 2,889,786 total(indirect: See footnote) - Sale
Common Stock
2018-06-13$7.97/sh−28,140$224,276→ 2,801,646 total(indirect: See footnote) - Sale
Common Stock
2018-06-13$6.59/sh−60,000$395,400→ 2,949,786 total(indirect: See footnote)
Footnotes (2)
- [F1]Common shares should pursuant to a trading plan pursuant to Rule 10b5-1. Price represents the gross sales price less commissions and brokerage fees.
- [F2]10X Fund, L.P. has direct beneficial ownership of all the securities owned by 10X Fund, L.P. 10X Capital Management, LLC, a Florida limited liability company, is the general partner of 10X Fund, L.P., a Delaware limited partnership, and may be deemed to have indirect beneficial ownership of all or a portion of the securities owned directly by 10X Fund, L.P. 10X Capital Management, LLC disclaims beneficial ownership of the reported securities except to the extent of its pecuniary interest therein.
Documents
Issuer
GALECTIN THERAPEUTICS INC
CIK 0001133416
Entity typeother
IncorporatedFL
Related Parties
1- filerCIK 0001457247
Filing Metadata
- Form type
- 4
- Filed
- Jun 13, 8:00 PM ET
- Accepted
- Jun 14, 7:32 PM ET
- Size
- 12.7 KB